Today: 22 December 2025
Subscribe
Browse Tag

stock upgrade

Bristol-Myers Squibb (BMY) Stock News Today: BofA Upgrade, Dividend Momentum and 2026 Pipeline Catalysts in Focus (Dec. 16, 2025)

Bristol-Myers Squibb (BMY) Stock News Today: BofA Upgrade, Dividend Momentum and 2026 Pipeline Catalysts in Focus (Dec. 16, 2025)

Bristol-Myers Squibb Company (NYSE: BMY) is back in the spotlight on Tuesday, December 16, 2025, as investors weigh a fresh Bank of America upgrade, a renewed value debate around the stock’s multiple, and a growing list of 2026 pipeline catalysts
16 December 2025
 ·  ·  ·  ·  · 
Coherent Corp. (COHR) Stock: JPMorgan Raises Target to $215 as AI Data-Center Catalysts Drive Fresh Focus (Dec. 15, 2025)

Coherent Corp. (COHR) Stock: JPMorgan Raises Target to $215 as AI Data-Center Catalysts Drive Fresh Focus (Dec. 15, 2025)

As of Monday, December 15, 2025, Coherent Corp. (NYSE: COHR) is back in the spotlight after a new wave of analyst commentary and product momentum rekindled investor interest in the photonics and advanced materials name. The stock traded around $180
15 December 2025
 ·  ·  ·  ·  · 
Akamai Technologies (AKAM) Stock Jumps After KeyBanc Double Upgrade to Overweight and $115 Target — Edge Compute Momentum Takes Center Stage (Dec. 15, 2025)

Akamai Technologies (AKAM) Stock Jumps After KeyBanc Double Upgrade to Overweight and $115 Target — Edge Compute Momentum Takes Center Stage (Dec. 15, 2025)

Akamai Technologies, Inc. (NASDAQ: AKAM) is getting a jolt of Wall Street adrenaline on Monday, December 15, 2025, with the stock rising about 4% in intraday trading. Shares were recently around $89.33, up roughly $3.45 from the prior close. The
15 December 2025
 ·  ·  ·  ·  · 
Eli Lilly (LLY) Pops on Fresh Deal Spree: MeiraGTx Gene Therapy Tie‑Up, New AI Collaboration, and Leerink Upgrade — Nov. 10, 2025

Eli Lilly (LLY) Pops on Fresh Deal Spree: MeiraGTx Gene Therapy Tie‑Up, New AI Collaboration, and Leerink Upgrade — Nov. 10, 2025

Eli Lilly and Company (NYSE: LLY) opened the week with a burst of dealmaking and Wall Street momentum. The pharma giant announced a rights deal for a pediatric blindness gene therapy from MeiraGTx, unveiled a new AI‑driven discovery partnership, and
10 November 2025
 ·  ·  ·  ·  ·  ·  ·  · 
Go toTop